MOLECULIN BIOTECH INC's ticker is MBRX and the CUSIP is 60855D200. A total of 23 filers reported holding MOLECULIN BIOTECH INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,123 | -26.4% | 14,305 | -0.5% | 0.00% | – |
| Q2 2023 | $8,323 | +69258.3% | 14,374 | +16.6% | 0.00% | – |
| Q1 2023 | $12 | +100.0% | 12,329 | +130.2% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 5,355 | -45.2% | 0.00% | – |
| Q3 2022 | $10,000 | +66.7% | 9,772 | +133.8% | 0.00% | – |
| Q2 2022 | $6,000 | -14.3% | 4,180 | -0.3% | 0.00% | – |
| Q1 2022 | $7,000 | – | 4,191 | +10377.5% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 40 | -98.4% | 0.00% | – |
| Q2 2021 | $9,000 | – | 2,513 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 1,036,853 | $1,099,064 | 0.41% |
| JMAC ENTERPRISES LLC | 13,132 | $13,920 | 0.00% |
| Virtu Financial LLC | 13,791 | $15 | 0.00% |
| Sigma Planning Corp | 57,500 | $60,950 | 0.00% |
| VANGUARD GROUP INC | 1,080,122 | $1,144,930 | 0.00% |
| UBS Group AG | 11,243 | $11,918 | 0.00% |
| MASSMUTUAL TRUST CO FSB/ADV | 167 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 968 | $1,354 | 0.00% |
| FMR LLC | 2 | $2 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 6,683 | $7,084 | 0.00% |